Fetal human neural progenitors can be the target for tumor transformation

NeuroReport

Volumn 15, Issue 12, 2004, Pages 1907-1912

  Wang, Yajun ^a   Bai, Yun ^a   Li, Xiaoxia ^a   Hu, Qikuan ^a   Lin, Changsheng ^a   Xiao, Zhifeng ^a   Liu, Yinan ^a   Xu, Jinchong ^a   Shen, Li ^a   Li, Linsong ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

hNPCs; hTERT; Mutation; Neoplasia; Transformation

Indexed keywords

TELOMERASE;

ARTICLE; CANCER CELL; CELL TRANSFORMATION; CELL TRANSPLANTATION; CONTROLLED STUDY; DIPLOIDY; FEASIBILITY STUDY; HUMAN; HUMAN CELL; KARYOTYPE; MOUSE; NERVE CELL; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STEM CELL; TARGET CELL;

ANIMALS; BLOTTING, SOUTHERN; CARRIER PROTEINS; CELL COUNT; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DNA; FETUS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; INTERMEDIATE FILAMENT PROTEINS; KARYOTYPING; MICE; MICE, NUDE; MICROTUBULE-ASSOCIATED PROTEINS; NERVE TISSUE PROTEINS; NEURONS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STAINING AND LABELING; STEM CELLS; TELOMERE; TIME FACTORS; TRANSDUCTION, GENETIC; TUBULIN;

EID: 4444376699     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200408260-00015     Document Type: Article

References (22)

1. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J and Dirks PB. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003; 63:5821-5828.
2. Hemmati HD, Nakano I, Lazareff JA, Masterman-Smith M, Geschwind DH, Bronner-Fraser M et al. Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci USA 2003; 100:15178-15183.
3. AlHajj M, Wicha MS, Benito-Hernandez A, Morrison SJ and Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003; 100:3983-3938.
4. Bonnet D and Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Med 1997; 3:730-737.
5. Park CH, Bergsagel DE and McCulloch EA. Mouse myeloma tumor stem cells: a primary cell culture assay. J Natl Cancer Inst 1971; 46:411-422.
6. Reya T, Morrison SJ, Clarke MF and Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001; 414:105-111.
7. Marx J. Cancer research. Mutant stem cells may seed cancer. Science 2003; 301:1308-1310.
8. Miyamoto T, Weissman IL and Akashi K. AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation. Proc Natl Acad Sci USA 2000; 97:7521-7526.
9. Traver D, Akashi K, Weissman IL and Lagasse E. Mice defective in two apoptosis pathways in the myeloid lineage develop acute myeloblastic leukemia. Immunity 1998; 9:47-57.
10. Reynolds BA and Weiss S. Generation of neurons and asrrocytes from isolated cells of the adult mammalian central nervous system. Science 1992; 255:1707-1710.
11. Brustle O, Spiro AC, Karram K, Choudhary K, Okabe S and McKay RD. In vitro-generated neural precursors participate in mammalian brain development. Proc Natl Acad Sci USA 1997; 94:14809-14814.
12. Tsai RY and McKay RD. A nucleolar mechanism controlling cell proliferation in stem cells and cancer cells. Genes Dev 2002; 16:2991-3003.
13. Molofsky AV, Pardal R, Iwashita T, Park IK, Clarke MF and Morrisom SJ. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 2003; 425:962-967.
14. Holland EC, Celestino J, Dai C, Schaefer L, Sawaya RE and Fuller GN. Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nature Genet 2000; 25:55-57.
15. Dai C, Celestino JC, Okada Y, Louis DN, Fuller GN and Holland EC. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes Dev 2001; 15:1913-1925.
16. Serakinci N, Guldberg P, Burns JS, Abdallah B, Schrodder H, Jensen T and Kassem M. Adult human mesenchymal stem cell as a target for neoplastic transformation. Oncogene 2004; 23:5095-5098.
17. Baum C, Dullmann J, Li Z, Fehse B, Meyer J, Williams DA and von Kalle C. Side effects of retroviral gene transfer into hematopoietic stem cells. Blood 2003; 101:2099-2114.
18. Chang S, Khoo CM, Naylor ML, Maser RS, DePinho RA. Telomere-based crisis: functional differences between telomerase activation and ALT in tumor progression. Genes Dev 2003; 17:88-100.
19. Stewart SA, Hahn WC, O'Connor BF, Banner EN, Lundberg AS, Modha P et al. Telomerase contributes to tumorigenesis by a telomere length-independent mechanism. Proc Natl Acad Sci USA 2002; 99:12606-12611.
20. Roy NS, Nakano T, Keyoung HM, Windrem M, Rashbaum WK, Alonso ML et al. Telomerase immortalization of neuronally restricted progenitor cells derived from the human fetal spinal cord. Nature Biotechnol 2004; 22:297-305.
21. Bai Y, Hu Q, Li X, Wang Y, Lin C and Li L. Telomerase immortalization of human neural progenitor cells. Neuroreport 2004; 15:245-249.
22. Sorrentino BP. Gene therapy to protect haematopoietic cells from cytotoxic cancer drugs. Nature Rev Cancer 2002; 2:431-441.